Biology Reference
In-Depth Information
Heikaus CC, Pandit J, Klevit RE (2009) Cyclic nucleotide binding GAF domains from phospho-
diesterases: structural and mechanistic insights. Structure 17:1551-1557
Holtmaat AJ, Trachtenberg JT, Wilbrecht L, Shepherd GM, Zhang X, Knott GW,
Svoboda K (2005) Transient and persistent dendritic spines in the neocortex in vivo. Neuron
45:279-291
Houslay MD (2001) PDE4 cAMP-specific phosphodiesterases. Prog Nucleic Acid Res Mol Biol
69:249-315
Houslay MD (2010) Underpinning compartmentalised cAMP signalling through targeted cAMP
breakdown. Trends Biochem Sci 35:91-100
Houslay MD, Schafer P, Zhang KY (2005) Keynote review: phosphodiesterase-4 as a therapeutic
target. Drug Discov Today 10:1503-1519
Houslay MD, Baillie GS, Maurice DH (2007) cAMP-Specific phosphodiesterase-4 enzymes in the
cardiovascular system: a molecular toolbox for generating compartmentalized cAMP signal-
ing. Circ Res 100:950-966
Hu H, McCaw EA, Hebb AL, Gomez GT, Denovan-Wright EM (2004) Mutant huntingtin affects
the rate of transcription of striatum-specific isoforms of phosphodiesterase 10A. Eur J Neurosci
20:3351-3363
Impey S, Mark M, Villacres EC, Poser S, Chavkin C, Storm DR (1996) Induction of CRE-
mediated gene expression by stimuli that generate long-lasting LTP in area CA1 of the
hippocampus. Neuron 16:973-982
Itoh T, Tokumura M, Abe K (2004) Effects of rolipram, a phosphodiesterase 4 inhibitor, in
combination with imipramine on depressive behavior, CRE-binding activity and BDNF level
in learned helplessness rats. Eur J Pharmacol 498:135-142
Juilfs DM, Fulle HJ, Zhao AZ, Houslay MD, Garbers DL, Beavo JA (1997) A subset of olfactory
neurons that selectively express cGMP-stimulated phosphodiesterase (PDE2) and guanylyl
cyclase-D define a unique olfactory signal transduction pathway. Proc Natl Acad Sci USA
94:3388-3395
Kadoshima-Yamaoka K, Murakawa M, Goto M, Tanaka Y, Inoue H, Murafuji H, Nagahira A,
Hayashi Y, Nagahira K, Miura K, Nakatsuka T, Chamoto K, Fukuda Y, Nishimura T (2009)
ASB16165, a novel inhibitor for phosphodiesterase 7A (PDE7A), suppresses IL-12-induced
IFN-gamma production by mouse activated T lymphocytes. Immunol Lett 122:193-197
Kaulen P, Br
uning G, Schneider HH, Sarter M, Baumgarten HG (1989) Autoradiographic
mapping of a selective cyclic adenosine monophosphate phosphodiesterase in rat brain with
the antidepressant [3H]rolipram. Brain Res 503:229-245
Kelly MP, Brandon NJ (2009) Differential function of phosphodiesterase families in the brain:
gaining insights through the use of genetically modified animals. Prog Brain Res 179:67-73
Kelly MP, Logue SF, Brennan J, Day JP, Lakkaraju S, Jiang L, Zhong X, TamM, Sukoff Rizzo SJ,
Platt BJ, Dwyer JM, Neal S, Pulito VL, Agostino MJ, Grauer SM, Navarra RL, Kelley C,
Comery TA, Murrills RJ, Houslay MD, Brandon NJ (2010) Phosphodiesterase 11A in brain is
enchriched in ventral hippocampus and deletion cause psychiatric disease related phenotypes.
Neuroscience 107:8457-8462
Kleppisch T (2009) Phosphodiesterases in the central nervous system. Handb Exp Pharmacol 191:
71-92
Kobayashi T, Gamanuma M, Sasaki T, Yamashita Y, Yuasa K, Kotera J, Omori K (2003)
Molecular comparison of rat cyclic nucleotide phosphodiesterase 8 family: unique expression
of PDE8B in rat brain. Gene 319:21-31
Kotaleski JH, Blackwel Kim T (2010) Modelling the molecular mechanisms of synaptic plasticity
using systems biology approaches. Neuroscience 11:239-249
Kruuse C, SergeiD R, Tejvir S (2001) The role of cGMP hydrolyzing phosphodiesterase 1 and 5 in
cerebral artery dilatation. Eur J Pharmacol 420:55-65
Lee R, Wolda S, Moon E, Esselstyn J, Hertel C, Lerner A (2002) PDE7A is expressed in human
B-lymphocytes and is up-regulated by elevation of intracellular cAMP. Cell Signal 14:
277-284
€
